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CLINICAL INVESTIGATIONS 
Short-, medium-, and long-term follow-up after 
percutaneous transluminal coronary angioplasty 
for stable and unstable angina pectoris 
The first 840 consecutive patients who underwent percutaneous transluminal coronary 
angioplasty (PTCA) performed in the same institution were retrospectively assessed at an 
average follow-up period of 25 months after the initial procedure. The study population consisted 
of 506 patients with stable angina pectoris (group 1) and 334 patients with unstable angina 
pectoris (group 2). Clinical end points were death, nonfatal myocardial infarction, recurrent 
angina pectoris necessitating bypass surgery or repeat PTCA, and event-free survival. The two 
groups were comparable with respect to age, sex, previous myocardial infarction, ejection 
fraction, and number of diseased vessels. PTCA was successful in 83.0% of group 1 and 87.1% 
of group 2. Follow-up rates were expressed as events per attempted PTCA in a patient group. No 
difference in survival was observed between the two groups, the mortality rate being 
approximately 2.8% at 25 months. In the group with stable angina pectorls there was a lower 
incidence of nonfatal myocardial infarction within the first 24 hours after angioplasty; 4.3% vs 
9.0% (p < 0.01). During long-term follow-up the increase in the incidence of nonfatal myocardial 
infarction was similar, resulting in an overall long-term follow-up infarction rate of 8.3% and 
14.2%, respectively (p < 0.01). A higher event-free survival was observed in group 1 within 24 
hours after PTCA: 93.7% vs 84.2% (p < 0.01). During subsequent follow-up the difference in 
event-free survival between the two groups was no longer significant: 68.5% vs 61.2%. These 
results suggest that PTCA is an effective long-term treatment for both patients with stable and 
unstable angina pectoris but with an initially higher major complication rate in the latter patient 
group. (AM HEART J 1989;117:991.) 
Otto Kamp, MD, Kevin J. Beatt, MD, Pim J. De Feyter, MD, 
Marcel van den Brand, MD, Harry Suryapranata, MD, Hans E. Luijten, MD, and 
Patrick W. Serruys, MD, Phd. Rotterdam, The Netherlands 
The effectiveness of percutaneous transluminal cor- 
onary angioplasty (PTCA) for the treatment of 
coronary artery disease has been documented in 
stable and unstable angina pectoris.‘*13 The long- 
term efficacy of PTCA in patients with coronary 
artery disease has also been documented,” 14-16 with 
follow-up periods extending as far as 8 years.13 It has 
been shown that PTCA combined with pharmaco- 
logic therapy can be performed relatively safely and 
From the Catheterization Laboratory, Thoraxcenter. 
Supported by a Joint Fellowship from the British and Netherlands Heart 
Foundations (Dr. Be&t). 
Received for publication Sept. 8, 1988; accepted Jan. 12, 1989. 
Reprint requests: Patrick W. Serruys, MD, PbD, Catheterization Labora- 
tory, Thoraxcenter, Bd 414, PO Box 1738, 3000 DR Rotterdam, The 
Netherlands. 
successfully in patients with refractory unstable 
angina pectoris. l* 4* 6-11 Available data2* 3, l3 suggest that 
significant numbers of all patients treated with 
PTCA are at risk for recurrent coronary events 
(16 % to 50 % 1. A higher early unfavorable outcome 
with regard to major complications has been demon- 
strated in patients with unstable angina pectoris 
after PTCA,‘s6-” but the longer-term outlook of 
these patients remains unclear. 
Results of follow-up studies in both medically and 
surgically treated patients with unstable angina 
pectoris have reported an increased risk of myocar- 
dial infarction and death within the first year.“-lg 
After treatment with PTCA this group of patients 
maintains a higher risk of myocardial infarction 
when compared to patients with stable angina pec- 
toris.6-11 The purpose of this study was to evaluate 
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Table I. Clinical characteristics of patients with stable and 
unstable angina pectoris 
Clinicc4l 
characteristics 
Group 1 
(stable AP) 
Group 2 
(unstable AP) 
No. of 
patients 
Age (yr) 
Median 
Range 
Sex (% male) 
Previous MI 
( 7; ) 
Ejection 
fraction 
Success rate 
(7;) 
506 334 
55 54 @IS) 
22-79 22-80 WS) 
80.9 80.2 WS) 
35.4 39.1 (NS) 
0.60 0.59 (W 
83.0 87.1 (NW 
AP = angina pectoris; MI = myocardial infarction; NS = not significant. 
the results of short-, medium-, and long-term follow- 
up of patients undergoing PTCA for stable and 
unstable angina pectoris in the same institution. 
Three follow-up time periods were analyzed: (1) 
short-term follow-up during which acute events 
occurred within the first 24 hours of the procedure; 
(2) medium-term follow-up; when events occurred 
within 6 months after PTCA, the period in which 
restenosis is most likely to occur, and (3) long-term 
follow-up, when events occurred from 6 months to 
the last follow-up. Patients with stable angina pec- 
toris treated with PTCA were compared with 
patients with unstable angina pectoris with regard 
to death, nonfatal myocardial infarction, and recur- 
rent angina pectoris necessitating coronary bypass 
surgery or repeat PTCA, and event-free survival. 
129 patients (58.9%) with stable angina pectoris and 90 
patients (41.1% ) with unstable angina pectoris; after this 
date steerable balloon systems were used. 
METHODS 
Primary success was defined as a reduction in the 
diameter of the dilated vessel to less than 50% diameter 
stenosis with no major complications, namely, death, 
myocardial infarction, or coronary artery bypass grafting, 
within 24 hours of the procedure. Procedural details 
including complications were recorded at the time of the 
procedure in the data base designed for this purpose. 
Primary end points considered at follow-up were death, 
nonfatal myocardial infarction, recurrent angina pectoris 
necessitating coronary artery bypass grafting or repeat 
PTCA, and event-free survival. These data were retro- 
spectively obtained by interview during outpatient visit(s) 
and by questionnaires in 96% of the patients. The mean 
follow-up was 25 months, ranging from 6 to 66 months. 
Between September 1980 and November 1985, PTCA Follow-up data included all patients after attempted 
was performed in 840 consecutive patients at the Thorax- PTCA. All patients’ names were checked at the civil 
center in Rotterdam. The study population consisted of registry to confirm survival at follow-up or death. This 
506 patients (60.2%) with stable angina pectoris and 334 part of the assessment was completed in The Netherlands 
patients (39.8%) with unstable angina pectoris. Unstable and is a reliable and complete source of information 
angina pectoris was defined as chest pain at rest lasting for concerning survival. Evidence qf myocardial infarction 
at least 15 minutes, associated with documented ST or T immediately after the procedure was defined by a new Q 
wave changes and no signs of myocardial necrosis (cardiac wave, elevation of myocardial enzymes (oxaloacetic trans- 
enzyme rise less than twice normal and no pathological Q aminase) lactate dehydrogenase, and/or creatine phospho- 
waves (~0.03 second). All patients were treated with a kinase to more than twice the normal level), or both. 
combination of intensive pharmacologic therapy, includ- Assessment of late myocardial infarction in the follow-up 
ing beta-blockers, calcium antagonists, nitrates, and hepa- period included a history of prolonged chest pain necessi- 
rin intravenously. Before PTCA 250 mg acetylsalicylic tating hospitalization and documented records and/or 
acid and 100 mg heparin were given intravenously. The ECG criteria for myocardial infarction (new Q waves). 
patients continued to receive treatment with nifedipine, Information on coronary bypass surgery and repeat PTCA 
40 to 60 mg/day, and acetylsalicylic acid, 500 mglday, for a were obtained from hospital data bases, outpatient vis- 
period of 6 months. The method of PTCA changed during it(s), or questionnaires. The 4% of patients from whom 
the enrollment period of this study: before February 1983 detailed follow-up data were not obtained were all residing 
(25.6 % of the procedures) a nonsteerable catheter system abroad at the time of attempted contact. Procedural 
was used, as originally described by Gruentzig et al.,2o in complications were included in all follow-up analyses. 
Table II. Angiographic characteristics of patients with 
stable and unstable angina pectoris 
- 
Group 1 Group 2 
(Stable AP) (Unstable AP) 
(N= 506) (N = 334) 
Angiographic __-__ 
characteristics N% N% 
Diagnostic catheterization 
l-Vessel disease 320 63.2% 214 64.1% (NS) 
2-Vessel disease 112 22.1% 75 22.4% (NS) 
S-Vessel disease 61 12.1% 40 12.0% (NS) 
Mainstem disease 13 2.6% 5 1.5% WS) 
PTCA 
I-Vessel 453 89.5% 310 92.8% (NW 
dilatation 
Multivessel 53 10.5% 24 7.2% (NS) 
dilatation 
Multidilatation of 106 20.9% 56 16.8% (NS) 
1 vessel 
Abbreviations as in Table I. 
Volume 117 
Number 5 
- UNSTABLE AP 
PTCA in stable and unstable angina 993 
--- STABLE AP 
94 - 
92 - PAIENrS AT RISN 
506 640 6TMl.6 204 aa i4a w Am.6 141 :: 
90 L 
0 i i ; 
TIME AFTER PTCA WEARS) 
Fig. 1. Effect of PTCA on long-term cumulative survival, analyzed by Kaplan-Meier method, up to 3 
years for patients with stable and unstable angina pectoris. Number of patients at risk is placed along 
horizontal axis. 
Patknt selection. In 506 patients PTCA was performed 
for stable angina pectoris (group 1) and in 334 patients for 
unstable angina pectoris (group 2). Baseline clinical char- 
acteristics (age, sex, previous myocardial infarction, and 
ejection fraction) were similar in both groups (Table I). 
No difference in vessel disease was observed between the 
two groups (Table II). Single-vessel disease was present in 
63.2% of the patients in group 1 versus 64.1% of the 
patients in group 2. In the group with stable angina 
pectoris a trend toward more multivessel dilatations 
(10.5% vs 7.3 % ) and more multidilatations of one vessel 
(20.9% vs 16.9% ) was noticed. 
Statistical analaysis. The differences between the two 
groups for categoric variables were assessed with the 
&i-square test. Survival data were analyzed by the 
Kaplan-Meier m.ethod of actuarial survival probability 
(Fig. 1). 
RESULTS 
The overall primary success rate was 83.0% in 
group 1 versus 87.1% in group 2. 
Short-term follow-up. In the group with unstable 
angina pectoris the incidence of acute nonfatal 
myocardial infarction within 24 hours was signifi- 
cantly higher (9.0% vs 4.3%) (Fig. 2). No significant 
difference in acute mortality, acute bypass surgery, 
or repeat PTCA was observed. The event-free sur- 
vival rate was therefore significantly higher in the 
group with stable angina pectoris, 93.7% versus 
84.2% within the first 24 hours (Fig. 3). 
Medium-term folfow-up. At the end of 6 months, the 
period in which restenosis is most likely to occur, an 
increased rate of coronary artery bypass grafting was 
present in the group with unstable angina pectoris: 
17.5% versus 13.2% within 6 months. This was also 
true for the incidence of nonfatal myocardial infarc- 
tion within the first 6 months (Fig. 2): 11.2% versus 
6.0%. The difference in nonfatal myocardial infarc- 
tion within 6 months was mainly due to the higher 
incidence of myocardial infarction within the first 24 
hours after PTCA. There was no difference in the 
mortality, repeat PTCA, or event-free survival in 
this period. 
Long-term follow-up. The actuarial survival curves 
between the two groups were not significantly differ- 
ent (Fig. 1). One-year survival in group 1 was 
98 + 1% versus 97 it 1% ; 3-year survival was 96 f 
3 % (group 1) versus 95 + 4% (group 2). Forty of the 
44 deaths were cardiac, and four were noncardiac. 
The difference in the incidence of nonfatal myocar- 
dial infarction between the two groups persisted at 
long-term follow-up; 14.2 % in the group with unsta- 
ble angina pectoris and 8.3% in the group with 
stable angina pectoris. This was also true for the 
difference in the incidence of coronary artery bypass 
grafting at long-term follow-up: 20.8% versus 
14.7%. During subsequent follow-up no difference 
in repeat PTCA between the two groups was 
noticed. The event-free survival in the two groups at 
long-term follow-up was no longer significant. 
DISCUSSION 
The purpose of this study was to evaluate the 
short-, medium-, and long-term follow-up of 
patients undergoing PTCA for both stable and 
unstable angina pectoris in the same institution. To 
determine whether patients with stable angina pec- 
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Fig. 2. Comparison of cumulative death (upper left), nonfatal myocardial infarction (upper right), 
coronary artery bypass grafting (lower left), and repeat PTCA (lower right) in patients with stable and 
unstable angina pectoris, within 24 hours (acute), within 6 months (<6 mths), and at follow-up (F-U). 
toris differ from those with unstable angina pectoris 
in terms of major complications, the clinical out- 
come of each group after coronary angioplasty was 
evaluated at a mean follow-up period of 25 months, 
with a follow-up rate of 96% for major events. No 
statistical significance in success rate was observed 
between the two groups. 
After the introduction of the steerable balloon 
system in February 1983, there was an improvement 
in the success rate for both groups from approxi- 
mately 70% to 90% with an overall success rate of 
83.0% in the group with stable angina pectoris and 
87.1% in the group with unstable angina pectoris. 
Results of recent studies have reported success rates 
of 93 % , which represents a significant improvement 
from the success rates of earlier studies”-12g 14-21 as a 
result of increased experience of the operators and 
improvement in procedures, balloon catheters, 
wires, and x-ray equipment.23 In this study the fact 
that all patients were included, starting from the 
first PTCA procedure and extending over 5 years, 
was responsible for the lower success rates. 
Short-term follow-up. The incidence of acute mor- 
tality related to the PTCA procedure was 0.6% in 
patients with stable angina pectoris, and no acute 
deaths occurred among patients with unstable angi- 
na pectoris in this series. This compares favorably 
with data from the National Heart, Lung, and Blood 
Institute PTCA registry,3 which reported a 1.1% 
in-hospital mortality rate. 
Within the first 24 hours after angioplasty there 
were significantly more events among the patients 
with unstable angina pectoris, mainly because of the 
difference in incidence of acute nonfatal myocardial 
infarction. This higher incidence of post-PTCA non- 
fatal myocardial infarction in patients first seen 
with unstable angina pectoris was observed particu- 
larly during or immediately after coronary angio- 
p1asty. 
This is probably related to the more complicated 
coronary lesions containing thrombus and thrombo- 
genie material,24-n which may more readily induce 
total occlusion during the procedure resulting in 
myocardial infarction. Our investigakx+ baa previ- 
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ously identified a subgroup of patients with unstable 
angina pectoris with marked ST elevation or persis- 
tent negative T waves who have an increased risk of 
a major procedural-related complication after 
PTCA. 
Medium-term follow-up. The event-free survival 
rate within a half year remained high in both 
groups-75.7% in group 1 versus 71.6% in group 
2-suggesting clinically important events in 24.3% 
(group 1) and 28.4% (group 2) in the period when 
restenosis is most likely to occur, with no significant 
difference between the groups. 
It was our policy to treat restenosis with a second 
PTCA rather than coronary bypass surgery. The 
occurrence of restenosis was the same in patients 
with stable angina pectoris and unstable angina 
pectoris, as expressed by the event rates. 
This was also shown in a recent study that used 
quantitative angiographic data. In a subgroup of this 
patient cohort the cumulative incidence of resteno- 
sis was similar in patients with stable angina pecto- 
ris (n = 206) and unstable angina pectoris (n = 133), 
irrespective of the type of definition. If a loss of at 
least 50% of the gain in luminal diameter achieved 
at the time of PTCA is used as a definition of 
restenosis, the rates are 26.7% for stable angina 
pectoris and :!4.8% for unstable angina pectoris, 
which is not statistically significant.2g 
Long-term follow-up. The l-year survival rate 
among patients after PTCA with stable angina 
pectoris was 98 % versus 97 % in those with unstable 
angina pectoris; the 3-year survival rates were 96% 
and 95 % , respectively. The difference was not sta- 
tistically significant. The mortality rate of 2.8% at 
25 months in our patients was similar to the out- 
come of both t:he medical and surgical treatment of 
stable and unstable angina pectoris.1B~30,31 The 
National Heart, Lung, and Blood Institute PTCA 
registry3 has re:ported an annual mortality rate after 
PTCA in all patients with one-vessel disease of less 
than 1% a year and 3% a year in patients with 
multivessel disease. During subsequent follow-up 
there was an increased rate of coronary bypass 
surgery in the group with unstable angina pectoris, 
which again can be partially explained by our policy 
or initially dilating only the culprit lesion. There was 
a trend toward a higher incidence of multivessel 
dilatation and multidilatation of one vessel in the 
group with stable angina, because in unstable angina 
pectoris and multivessel disease only the culprit 
lesion was dilated in the majority of the patients, 
that is, the lesion judged by ECG and anatomic 
location to be the lesion responsible for the ische- 
mia.7*21 It is inevitable, if the policy of treating only 
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Fig. 3. Comparison of cumulative figures of time-related, 
event-free survival in patients with stable and unstable 
angina pectoris, within 24 hours (acute), within 6 months 
(<6 mths), and at follow-up (F-U). 
the culprit lesion is adopted, that some patients will 
not undergo complete revascularization and there- 
fore further intervention in the future might be 
expected. The higher incidence of surgery in the 
patients with unstable angina reflects this incom- 
plete revascularization. No difference in repeat 
PTCA was observed during follow-up between the 
two groups. 
From 6 months until follow-up the event-free 
survival rates were reduced to 68.5% (group 1) and 
61.2% (group 2). The majority of the events were 
related to progression of the atherosclerotic disease 
in nondilated coronary artery segments. In conclu- 
sion, PTCA is an effective long-term treatment for 
both stable and unstable angina pectoris but with an 
initially higher major complication rate for patients 
with unstable angina pectoris. 
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also indebted to Anja van Huuksloot and Claudia Sprenger de 
Rover for expert preparation of this manuscript. 
REFERENCES 
1. Meyer J, Schmitz HJ, Kiesslich T, et al. Percutaneous 
transluminal coronary angioplasty in patients with stable and 
unstable angina pectoris: analysis of early and late results. AM 
HEART J 1983;106:973-80. 
2. Dorros G, Cowley MJ, Simpson J, et al. Percutaneous trans- 
luminal coronary angioplasty: report of complications from 
the National Heart, Lung, and Blood Institute PTCA regis- 
try. Circulation 1983;67:723-30. 
3. Kent KM, Bentivoglio LG, Block PC, et al. Long-term 
efficacy of percutaneous transluminal coronary angioplasty 
(PTCA): report from the National Heart, Lung, and 
Blood Institute PTCA registry. Am J Cardiol 1984;53: 
27c-31~. 
996 Kamp et al. 
May 1999 
American Heart Journal 
4. 
5. 
6. 
I. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
Williams DO, Riley RS, Singh AK, Gewirtz H, Most AS. 
Evaluation of the role of coronary angioplasty in patients 
with unstable angina pectoris. AM HEART J 1981;102:1-9. 
Faxon DP, Detre KM, McGabe CH, et al. Role of percutane- 
ous coronary angioplasty in the treatment of unstable angina. 
Am J Cardiol 1983;5:131c-135c. 
de Feyter PJ, Serruys PW, Wijns W, et al. Emergency PTCA 
in refractory unstable angina. N Engl J Med 1985;313:342- 
6. 
de Feyter PJ, Serruys PW, Arnold A, et al. Coronary angio- 
plasty of the unstable angina related vessel in patients with 
multivessel disease. Eur Heart J 1986:7:460. 
de Feyter PJ, Serruys PW, Suryapranata H, Beatt K, van den 
Brand M. Coronary angioplasty early after diagnosis of 
unstable angina. AM HEART J 1987;114:48-54. 
Quigley PJ, Erwin J, Maurer BJ, Walsh MJ, Gearty GF. 
Percutaneous transluminal coronary angioplasty in unstable 
angina: comparison with stable angina. Br Heart J 1986; 
55:227-30. 
Timmis AD, Griffin B, Crick JCP, Sowton E. Early percuta- 
neous transluminal coronary angioplasty in the management 
of unstable angina. Int J Cardiol 1987;14:25-31. 
Steffenino G, Meier B, Finci L, Rutishauser W. Follow-up 
results of treatment of unstable angina by coronary angio- 
plasty. Br Heart J 1987;57:416-19. 
Rosing DR, Cannon RO, Watson RM, et al. Three year 
anatomic, functional and clinical follow-up after successful 
percutaneous transluminal coronary angioplasty. J Am Co11 
Cardiol 1987;9:1-7. 
Gruentzig RA, King SB, Schlumpf M, Siegenthaler W. Long- 
term follow-up after percutaneous transluminal coronary 
angioplasty. N Engl J Med 1987;316:1127-32. 
Mabin TA, Holmes DR, Smith HC, et al. Follow-up clinical 
results in patients undergoing percutaneous transluminal 
coronarv aneionlastv. Circulation 1985:71:754-60. 
Holmes”DR:Vhets&a RE. Percutaneous transluminal coro- 
nary angioplasty: current status and future trends. Mayo Clin 
Proc 1986;61:865-76. 
Ernst SMPG, van den Feltz TA, Bal ET, van Bogerijen L, van 
den Berg E, Ascoop CAPL, Plokker HWT. Long-term angio- 
graphic follow-up, cardiac events, and survival in patients 
undergoing percutaneous transluminal coronary angioplasty. 
Br Heart J 1987;57:220-5. 
17. Gazes PC, Mobley Jr EM, Faris Jr HM, Duncan RC, Hum- 
phries GB. Preinfarctional (unstable) angina pectoris a pro- 
spective study: Ten-year follow-up. Circulation 1973;48: 
331-6. 
18. Russell Jr RO, Morashi RE, Kouchoukos N, et al. Unstable 
angina pectoris: national cooperative study group to compare 
surgical and medical therapy. Am J Cardiol 78;42:839-48. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
Cairns JA, Fantus IG, Klassen GA. Unstable angina pectoris. 
AM HEART J 1976;92:373. 
Gruentzig AR, Senning A, Siegenthaler WE. Non-operative 
dilatation of coronary artery stenosis. N Engl -.J Med 
1979;301:61-7. 
Wohlgelernter D, Cleman M, Highman HA, Zaret BL. Percu- 
taneous transluminal coronary angioplasty of the “culprit” 
lesion for management of unstable angina pectoris patients 
with multivessel coronary artery disease. Am J Cardiol 
1986;58:460-4. 
Giuliani ER. Percutaneous transluminal coronary angioplas- 
ty. J Am Co11 Cardiol 1985;6:992-4. 
Meier B, Gruentzig A. Learning curve for percutaneous 
transluminal coronary angioplasty: skill, technology or 
patient selection. Am J Cardiol 1984;53:65c-6c. 
Ambrose JA, Winters SL, Stern A, Eng A, Teichholtz LE, 
Gorlin R, Fuster A. Angiographic morphology and the patho- 
genesis of unstable angina pectoris. J Am Co11 Cardiol 
1983;5:609. 
Mabin TA, Holmes DR, Smith HC, et al. Intracoronary 
thrombus: role in coronary occlusion complicating percutane- 
ous transluminal coronary angioplasty. J Am Co11 Cardiol 
1985;5:198-202. 
Ischinger T, Gruentzig AR, Meier B, Galan K. Coronary 
dissection and total coronary occlusion associated with percu- 
taneous transluminal coronary angioplasty: significance of 
initial angiographic morphology of coronary stenosis. Circula- 
tion 1986;72:1371-8. 
de Feyter PJ, Suryapranata H, Serruys PW, Beatt KJ, van 
Domburg R, van den Brand M, Hugenholtz PG. Coronary 
angioplasty for unstable angina-immediate and late results 
in 200 consecutive patients with identification of risk factors 
for unfavorable early and late outcome. J Am Co11 Cardiol 
1988;12:324-33. - 
Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of 
restenosis after successful coronary angioplasty: a time- 
related phenomenon. Circulation 1988,77:361-71. 
Luijten HE, Beatt KJ, de Feyter PJ, van den Brand M, 
Reiber JHC, Serruys PW. Angioplasty for stable versus 
unstable angina: are unstable patients more likely to get 
restenosis. Int J Card Imaging 1988;3:87-97. 
Kennedy JW, Kaiser GC, Fisher LD, et al. Clinical and 
angiographic predictors of operative mortality from the Col- 
laborative Study in Coronary Artery Surgery (CASS). Circu- 
lation 1981;63:783-802. 
Luchi RJ, Scott SM, Deupress RH. Comparison of medical 
and surgical treatment for unstable angina pectoris. Results 
of a veterans administration cooperative study. N Engl J Med 
1987;316:977-84. 
